You need cookies enabled

HEFCE closed at the end of March 2018. The information on this website is historical and is no longer maintained.

Many of HEFCE's functions will be continued by the Office for Students, the new regulator of higher education in England, and Research England, the new council within UK Research and Innovation.

The HEFCE domain - www.hefce.ac.uk - will continue to function until September 2018. At this point we will close the site entirely and all its information will only be available from the National Web Archive.

Cookies

You need cookies enabled

It will focus on two main areas:

  • Translational research
    The project will create university research groups and spin-outs to develop therapies for clinical trials more effectively than at present.
  • Skilled researchers
    It will nurture the next generation of interdisciplinary clinicians, scientists, and engineers skilled in this area.

The project has three key objectives:

Advanced Industry-Ready Research Cluster (AIRC)

It will create an ‘Advanced Industry-Ready Research Cluster (AIRC)’.

This will bring together six world-leading translational research projects at the Stevenage Bioscience Catalyst (three each from University College London and the University of Cambridge).

The cluster will allow the projects to work together more effectively and productively, accelerating work on innovative therapies.

It will also build links with the new Francis Crick Institute and apply the basic research the institute carries out.

Interacting with Catapult Centres

The project will create a model for the way in which higher education institutions can interact with ‘Catapult Centres’. These centres provide shared space for businesses, scientists and engineers to develop new products from applied research.

The interactive model will give the centres  access to cutting-edge bioprocess technologies and research that is leading the way internationally. It will also support sustainable ways to develop therapies.

Next-generation training activities

Developing training activities for next-generation researchers is another key objective for the project.

These will focus on:

  • key aspects of drug discovery
  • bioprocessing and enterprise to deliver long-term project impact.

The project will establish teaching and careers fellows who will work with students and researchers at both University College London and the University of Cambridge.

Project information

Catalyst funding £3,000,000  
Total project funding £12,000,000
Project contact Professor Gary J Lye 
E-mail g.lye@ucl.ac.uk   
Tel 0207 679 7942  
Web-site www.ucl.ac.uk/biochemeng

Page last updated 25 January 2015

Related content